Evidence map›Paper›PMID 40024506›Full record

ArticleExperimental cell research2025

Low extracellular pH enhances TRAIL-induced apoptosis by downregulating Mcl-1 expression.

Farzaneh Vafaeinik, Lin Zhang, Yong J Lee

Abstract read
In one paragraph

Article in Experimental cell research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Farzaneh VafaeinikDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Lin ZhangDepartment of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA, 90007, USA; Norris Comprehensive Cancer Center, Keck School of Medicine of University of Southern California, Los Angeles, CA, 90007, USA.
Yong J LeeDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. Electronic address: yong.lee3@cshs.org.

Funding

Assessment of hyperthermia-based multimodal approach for hepatic colorectal metastasesR01CA265827 · NCI · CEDARS-SINAI MEDICAL CENTER · PI YONG JUN LEE · 2023 to 2026
$1.8M
Application of in vivo humanized PDX mouse model and ex vivo organoid model to assess the therapeutic efficacy of combinatorial therapy for pseudomyxoma peritoneiR21CA259243 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, YONG J · 2022 to 2023
$412k
NCI NIH HHS R01 CA265827NCI NIH HHS R21 CA259243
6 · The paper itself

Abstract

We previously reported that low extracellular pH promotes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through the mitochondria-mediated caspase signal transduction pathway. In this study, we further investigated the mechanism of low extracellular pH on TRAIL-induced apoptosis. When human colorectal carcinoma HCT116 cells were treated with TRAIL for 4 h, significant cytotoxicity was observed at pH 6.3, while cytotoxic effects were notably reduced at pH 7.2. These findings suggest that TRAIL's cytotoxic effects on human colorectal cancer cells are enhanced in low pH environments following TRAIL treatment. Similar results were observed in human pancreatic adenocarcinoma BxPC-3 cells. Interestingly, TRAIL was found to downregulate the levels of anti-apoptotic proteins, such as Mcl-1. This was confirmed by the knock-in (KI) of an Mcl-1 phosphorylation site mutant in HCT116 cells, which blocked TRAIL-induced Mcl-1 downregulation and the subsequent apoptotic response. These results indicate that Mcl-1 mediates TRAIL resistance in the Mcl-1 KI cells. Additionally, our results revealed that TRAIL significantly induced JNK phosphorylation in HCT116 cells, suggesting the involvement of JNK in TRAIL-induced cell death in colorectal cancer cells. Our findings demonstrate that low extracellular pH enhances TRAIL-induced cytotoxicity, particularly at pH 6.3 and 6.6. Moreover, the anti-apoptotic Bcl-2 family member Mcl-1 is an important target of TRAIL in colorectal carcinoma HCT116 cells under different low pH conditions. TRAIL triggered a rapid decline in Mcl-1, suggesting that Mcl-1 downregulation is crucial for TRAIL-induced apoptosis.

Indexed as

ApoptosisMyeloid Cell Leukemia Sequence 1 ProteinTNF-Related Apoptosis-Inducing LigandCell Line, TumorColorectal NeoplasmsDown-RegulationHCT116 CellsHumansHydrogen-Ion ConcentrationPhosphorylationMCL1 protein, humanMyeloid Cell Leukemia Sequence 1 ProteinTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanApoptosisColorectal cancerLow extracellular pHMCL-1TRAIL

Identifiers

PMID40024506
PMCPMC12340464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.